Insider Trading activities of Exelixis, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Exelixis, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Exelixis, Inc. since year 2005. Table 2 shows the detailed insider transactions of Exelixis, Inc. since 2005. The reporting company's ticker symbol is EXEL. The reporting company's CIK number is 939767.
The total value of stock buying since 2005 is $3,904,031.
The total value of stock sales since 2005 is $106,671,173.
The total value of stock option exercises since 2005 is $28,731,818.


 1   2   3 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Exelixis, Inc. (EXEL).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-12 0 $0 53,499 $1,130,148 13,499 $68,034
2018-11 0 $0 158,108 $2,753,786 74,499 $359,974
2018-10 0 $0 49,501 $882,507 24,501 $123,485
2018-09 0 $0 47,500 $838,175 22,500 $123,750
2018-08 0 $0 389,128 $7,858,514 545,100 $1,940,118
2018-07 0 $0 112,500 $2,378,700 112,500 $618,750
2018-06 0 $0 112,500 $2,233,800 112,500 $618,750
2018-05 0 $0 357,974 $7,563,237 212,250 $1,430,233
2018-04 0 $0 119,959 $2,476,869 194,591 $1,145,613
2018-03 0 $0 86,000 $2,075,130 93,293 $813,595
2018-02 0 $0 60,029 $1,615,536 28,625 $224,358
2018-01 0 $0 15,000 $454,515 15,000 $119,550
2017-09 0 $0 897,942 $23,919,083 527,302 $1,918,872
2017-05 0 $0 598,347 $13,258,833 591,860 $2,024,351
2017-04 0 $0 10,000 $213,000 20,090 $205,291
2017-03 0 $0 600,578 $13,508,762 616,257 $4,602,550
2017-02 0 $0 70,000 $1,305,500 70,000 $459,900
2017-01 0 $0 70,000 $1,046,500 70,000 $363,300
2016-12 0 $0 329,726 $5,741,547 485,332 $4,131,934
2016-11 0 $0 292,000 $4,250,500 292,000 $2,364,679
2016-08 0 $0 173,493 $1,905,799 175,000 $1,702,749
2016-06 0 $0 0 $0 200,000 $340,000
2016-05 60,000 $297,920 0 $0 0 $0
2015-12 100,000 $488,549 0 $0 0 $0
2015-11 0 $0 0 $0 5,208 $0
2015-10 0 $0 352,425 $2,055,775 352,425 $1,984,151
2014-11 0 $0 0 $0 11,646 $0
2014-09 20,000 $34,200 0 $0 0 $0
2014-02 0 $0 0 $0 12,268 $0
2013-11 0 $0 0 $0 17,473 $0
2013-08 10,000 $51,400 0 $0 12,266 $0
2013-05 0 $0 0 $0 12,264 $0
2013-02 0 $0 0 $0 12,267 $0
2012-12 35,000 $156,795 0 $0 0 $0
2012-11 0 $0 0 $0 17,474 $0
2012-08 0 $0 0 $0 12,266 $0
2012-06 0 $0 7,000 $35,917 0 $0
2012-05 0 $0 0 $0 12,264 $0
2012-02 0 $0 0 $0 12,267 $0
2011-11 0 $0 0 $0 12,265 $0
2011-08 0 $0 0 $0 14,844 $0
2011-05 0 $0 0 $0 19,842 $0
2011-02 0 $0 0 $0 74,376 $0
2010-12 0 $0 108,539 $835,207 104,427 $570,120
2010-09 36,200 $130,403 0 $0 0 $0
2010-08 446,500 $1,359,351 0 $0 0 $0
2009-12 0 $0 12,500 $98,625 12,500 $63,000
2009-11 0 $0 2,529 $15,657 0 $0
2009-06 0 $0 18,806 $94,165 0 $0
2008-10 392,500 $1,276,125 0 $0 0 $0
2008-03 0 $0 2,213 $11,014 0 $0
2008-02 0 $0 10,000 $65,801 0 $0
2008-01 0 $0 15,000 $111,424 0 $0
2007-12 0 $0 12,500 $111,060 0 $0
2007-11 0 $0 10,000 $93,659 0 $0
2007-10 0 $0 8,125 $97,987 0 $0
2007-07 0 $0 18,125 $212,640 0 $0
2007-06 0 $0 18,125 $211,961 0 $0
2007-05 0 $0 12,500 $140,573 0 $0
2007-04 0 $0 10,000 $107,738 0 $0
2007-03 0 $0 7,500 $72,427 0 $0
2007-02 0 $0 12,500 $132,011 0 $0
2007-01 0 $0 10,000 $96,134 0 $0
2006-12 0 $0 10,000 $91,002 0 $0
2006-11 0 $0 12,500 $108,246 0 $0
2006-10 0 $0 10,000 $96,404 0 $0
2006-09 0 $0 10,000 $91,296 0 $0
2006-08 0 $0 12,500 $107,187 0 $0
2006-07 0 $0 15,000 $139,701 0 $0
2006-06 0 $0 7,500 $75,509 0 $0
2006-05 0 $0 23,124 $244,909 15,624 $99,711
2006-04 0 $0 50,000 $559,354 40,000 $252,000
2006-03 0 $0 32,500 $366,599 10,000 $63,000
2006-02 0 $0 12,500 $127,875 0 $0
2006-01 0 $0 10,000 $106,898 0 $0
2005-12 0 $0 10,000 $90,154 0 $0
2005-11 0 $0 12,500 $104,842 0 $0
2005-10 0 $0 10,000 $74,889 0 $0
2005-09 0 $0 280,458 $2,187,008 0 $0
2005-04 0 $0 7,500 $55,527 0 $0
2005-03 0 $0 5,000 $33,557 0 $0
2004-03 2,800 $24,951 0 $0 0 $0
2004-02 7,200 $60,437 0 $0 0 $0
2002-04 2,000 $23,900 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Exelixis, Inc. insiders (EXEL)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-12-03 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Sale 13,499 21.02 283,748
2018-12-03 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Option Ex 13,499 5.04 68,034
2018-12-03 Scangos George A Sale 40,000 21.16 846,400
2018-11-30 Senner Christopher J. (EVP and CFO) Sale 8,791 19.70 173,182
2018-11-30 Hessekiel Jeffrey (EVP and General Counsel) Sale 1,943 19.91 38,685
2018-11-30 Scangos George A Sale 8,500 20.00 170,000
2018-11-29 Hessekiel Jeffrey (EVP and General Counsel) Sale 1,116 19.51 21,773
2018-11-29 Scangos George A Sale 6,500 20.00 130,000
2018-11-28 Hessekiel Jeffrey (EVP and General Counsel) Sale 11,759 19.12 224,832
2018-11-15 Morrissey Michael (President and CEO) Sale 25,000 17.22 430,500
2018-11-15 Morrissey Michael (President and CEO) Option Ex 25,000 4.42 110,500
2018-11-07 Haley Patrick J. (Sr. Vice President, Commercial) Sale 20,000 17.32 346,400
2018-11-02 Morrissey Michael (President and CEO) Sale 37,499 18.25 684,244
2018-11-02 Morrissey Michael (President and CEO) Option Ex 37,499 5.04 188,994
2018-11-01 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Sale 12,000 14.16 169,920
2018-11-01 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Option Ex 12,000 5.04 60,480
2018-11-01 Scangos George A Sale 25,000 14.57 364,250
2018-10-01 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Sale 12,000 17.77 213,240
2018-10-01 Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) Option Ex 12,000 5.04 60,480
2018-10-01 Scangos George A Sale 25,000 17.86 446,500
2018-10-01 Morrissey Michael (President and CEO) Sale 12,501 17.82 222,767
2018-10-01 Morrissey Michael (President and CEO) Option Ex 12,501 5.04 63,005
2018-09-24 Scangos George A Sale 25,000 16.85 421,250
2018-09-04 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 22,500 18.53 416,925
2018-09-04 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 22,500 5.50 123,750
2018-08-20 Morrissey Michael (President and CEO) Sale 90,000 18.20 1,638,000
2018-08-20 Morrissey Michael (President and CEO) Option Ex 90,000 5.50 495,000
2018-08-17 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 50,000 5.51 275,500
2018-08-15 Marchesi Vincent T Sale 40,000 19.50 780,000
2018-08-15 Marchesi Vincent T Option Ex 40,000 3.38 135,200
2018-08-10 Scangos George A Option Ex 108,333 4.73 512,415
2018-08-09 Morrissey Michael (President and CEO) Sale 34,267 20.91 716,522
2018-08-09 Morrissey Michael (President and CEO) Option Ex 34,267 1.70 58,253
2018-08-08 Morrissey Michael (President and CEO) Sale 100,000 21.02 2,102,000
2018-08-08 Morrissey Michael (President and CEO) Option Ex 100,000 1.70 170,000
2018-08-07 Morrissey Michael (President and CEO) Sale 100,000 21.10 2,110,000
2018-08-07 Morrissey Michael (President and CEO) Option Ex 100,000 1.70 170,000
2018-08-06 Haley Patrick J. (Sr. Vice President, Commercial) Sale 2,361 20.92 49,392
2018-08-01 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 22,500 20.56 462,600
2018-08-01 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 22,500 5.50 123,750
2018-07-16 Morrissey Michael (President and CEO) Sale 90,000 21.13 1,901,700
2018-07-16 Morrissey Michael (President and CEO) Option Ex 90,000 5.50 495,000
2018-07-02 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 22,500 21.20 477,000
2018-07-02 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 22,500 5.50 123,750
2018-06-25 Morrissey Michael (President and CEO) Sale 90,000 19.62 1,765,800
2018-06-25 Morrissey Michael (President and CEO) Option Ex 90,000 5.50 495,000
2018-06-01 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 22,500 20.80 468,000
2018-06-01 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 22,500 5.50 123,750
2018-05-31 Hessekiel Jeffrey (EVP and General Counsel) Sale 65,000 20.71 1,346,150
2018-05-30 Feldbaum Carl B Sale 34,262 20.60 705,797
2018-05-30 Feldbaum Carl B Option Ex 14,750 4.37 64,383
2018-05-24 Morrissey Michael (President and CEO) Sale 90,000 20.55 1,849,500
2018-05-24 Morrissey Michael (President and CEO) Option Ex 90,000 5.50 495,000
2018-05-22 Willsey Lance Sale 50,000 21.40 1,070,000
2018-05-18 Haley Patrick J. (Sr. Vice President, Commercial) Sale 3,663 21.61 79,157
2018-05-15 Scangos George A Option Ex 15,000 11.66 174,900
2018-05-11 Marchesi Vincent T Sale 15,000 19.03 285,450
2018-05-11 Marchesi Vincent T Option Ex 15,000 11.66 174,900
2018-05-09 Cohen Charles Sale 15,000 21.42 321,300
2018-05-09 Cohen Charles Option Ex 15,000 11.66 174,900
2018-05-07 Haley Patrick J. (Sr. Vice President, Commercial) Sale 15,000 22.00 330,000
2018-05-07 Haley Patrick J. (Sr. Vice President, Commercial) Option Ex 15,000 1.90 28,500
2018-05-07 Papadopoulos Stelios Sale 15,000 22.15 332,250
2018-05-07 Papadopoulos Stelios Option Ex 15,000 11.66 174,900
2018-05-04 Haley Patrick J. (Sr. Vice President, Commercial) Sale 12,549 22.38 280,846
2018-05-04 Haley Patrick J. (Sr. Vice President, Commercial) Option Ex 10,000 1.90 19,000
2018-05-04 Hessekiel Jeffrey (EVP and General Counsel) Sale 20,000 22.36 447,200
2018-05-03 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 22,500 22.91 515,587
2018-05-03 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 22,500 5.50 123,750
2018-04-27 Hessekiel Jeffrey (EVP and General Counsel) Option Ex 25,000 1.70 42,500
2018-04-24 Haley Patrick J. (Sr. Vice President, Commercial) Option Ex 20,000 1.70 34,000
2018-04-16 Garber Alan M Sale 15,000 20.25 303,750
2018-04-16 Garber Alan M Option Ex 15,000 11.66 174,900
2018-04-16 Wyszomierski Jack L Sale 14,959 20.25 302,919
2018-04-16 Wyszomierski Jack L Option Ex 30,000 9.81 294,450
2018-04-11 Morrissey Michael (President and CEO) Sale 90,000 20.78 1,870,200
2018-04-11 Morrissey Michael (President and CEO) Option Ex 90,000 5.50 495,000
2018-04-06 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 14,591 7.18 104,763
2018-03-06 Marchesi Vincent T Sale 15,000 24.73 370,950
2018-03-06 Marchesi Vincent T Option Ex 15,000 7.97 119,550
2018-03-05 Feldbaum Carl B Sale 11,000 23.88 262,680
2018-03-05 Feldbaum Carl B Option Ex 11,000 11.66 128,260
2018-03-05 Cohen Charles Sale 15,000 24.23 363,450
2018-03-05 Cohen Charles Option Ex 15,000 7.97 119,550
2018-03-02 Willsey Lance Sale 30,000 23.91 717,300
2018-03-02 Willsey Lance Option Ex 30,000 9.81 294,450
2018-03-02 Papadopoulos Stelios Sale 15,000 24.05 360,750
2018-03-02 Papadopoulos Stelios Option Ex 15,000 7.97 119,550
2018-03-01 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 7,293 4.42 32,235
2018-02-28 Haley Patrick J. (Sr. Vice President, Commercial) Sale 45,029 27.13 1,221,636
2018-02-28 Haley Patrick J. (Sr. Vice President, Commercial) Option Ex 13,625 3.63 49,458
2018-02-28 Poste George Sale 15,000 26.26 393,900
2018-02-28 Poste George Option Ex 15,000 11.66 174,900
2018-01-09 Garber Alan M Sale 11,500 30.00 345,000
2018-01-09 Garber Alan M Option Ex 11,500 7.97 91,655
2018-01-08 Garber Alan M Sale 3,500 31.29 109,515
2018-01-08 Garber Alan M Option Ex 3,500 7.97 27,895
2017-09-28 Hessekiel Jeffrey (EVP and General Counsel) Sale 25,000 24.32 608,000
2017-09-28 Hessekiel Jeffrey (EVP and General Counsel) Option Ex 25,000 1.90 47,500
2017-09-28 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 33,334 23.74 791,349
2017-09-28 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 33,334 9.91 330,339
2017-09-27 Hessekiel Jeffrey (EVP and General Counsel) Sale 2,302 23.90 55,017
2017-09-27 Hessekiel Jeffrey (EVP and General Counsel) Option Ex 2,302 1.90 4,373
2017-09-27 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 33,333 23.94 797,992
2017-09-27 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 33,333 9.91 330,330
2017-09-26 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 33,333 23.68 789,325
2017-09-26 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 33,333 9.91 330,330
2017-09-22 Papadopoulos Stelios Sale 10,000 25.40 254,000
2017-09-19 Papadopoulos Stelios Sale 127,790 27.63 3,530,837
2017-09-18 Papadopoulos Stelios Sale 72,210 27.76 2,004,549
2017-09-14 Haley Patrick J. (Sr. Vice President, Commercial) Sale 60,640 27.21 1,650,014
2017-09-14 Morrissey Michael (President and CEO) Sale 100,000 27.08 2,708,000
2017-09-14 Morrissey Michael (President and CEO) Option Ex 100,000 1.70 170,000
2017-09-13 Willsey Lance Sale 50,000 26.97 1,348,500
2017-09-13 Morrissey Michael (President and CEO) Sale 100,000 27.04 2,704,000
2017-09-13 Morrissey Michael (President and CEO) Option Ex 100,000 1.70 170,000
2017-09-12 Senner Christopher J. (EVP and CFO) Sale 100,000 26.79 2,679,000
2017-09-12 Senner Christopher J. (EVP and CFO) Option Ex 100,000 3.66 366,000
2017-09-12 Willsey Lance Sale 50,000 26.79 1,339,500
2017-09-12 Morrissey Michael (President and CEO) Sale 100,000 26.59 2,659,000
2017-09-12 Morrissey Michael (President and CEO) Option Ex 100,000 1.70 170,000
2017-05-30 Haley Patrick J. (Sr. Vice President, Commercial) Sale 5,000 18.46 92,300
2017-05-15 Feldbaum Carl B Sale 32,988 21.58 711,881
2017-05-15 Feldbaum Carl B Option Ex 19,000 9.81 186,485
2017-05-15 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 12,501 5.04 63,005
2017-05-10 Morrissey Michael (President and CEO) Sale 100,000 22.07 2,207,000
2017-05-10 Morrissey Michael (President and CEO) Option Ex 100,000 1.80 180,000
2017-05-09 Morrissey Michael (President and CEO) Sale 100,000 21.68 2,168,500
2017-05-09 Morrissey Michael (President and CEO) Option Ex 100,000 1.90 190,000
2017-05-08 Morrissey Michael (President and CEO) Sale 11,300 21.81 246,453
2017-05-08 Morrissey Michael (President and CEO) Option Ex 11,300 1.90 21,470
2017-05-05 Morrissey Michael (President and CEO) Sale 100,000 21.76 2,176,000
2017-05-05 Morrissey Michael (President and CEO) Option Ex 100,000 1.90 190,000
2017-05-04 Morrissey Michael (President and CEO) Sale 59,149 22.17 1,311,333
2017-05-04 Morrissey Michael (President and CEO) Option Ex 59,149 1.90 112,383
2017-05-03 Morrissey Michael (President and CEO) Sale 100,000 22.64 2,263,500
2017-05-03 Morrissey Michael (President and CEO) Option Ex 100,000 1.90 190,000
2017-05-01 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 89,910 23.16 2,081,866
2017-05-01 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 89,910 9.91 891,008
2017-04-17 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 10,090 9.91 99,991
2017-04-03 Marchesi Vincent T Sale 10,000 21.30 213,000
2017-04-03 Marchesi Vincent T Option Ex 10,000 10.53 105,300
2017-03-31 Wyszomierski Jack L Sale 5,150 21.57 111,085
2017-03-31 Wyszomierski Jack L Option Ex 10,000 10.53 105,300
2017-03-27 Hessekiel Jeffrey (EVP and General Counsel) Sale 6,884 21.02 144,701
2017-03-27 Cohen Charles Option Ex 10,000 10.53 105,300
2017-03-22 Hessekiel Jeffrey (EVP and General Counsel) Sale 23,787 20.54 488,584
2017-03-22 Hessekiel Jeffrey (EVP and General Counsel) Option Ex 55,000 1.70 93,500
2017-03-20 Feldbaum Carl B Sale 10,000 21.77 217,700
2017-03-20 Feldbaum Carl B Option Ex 10,000 10.53 105,300
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of EXEL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Exelixis, Inc. (symbol EXEL, CIK number 939767) see the Securities and Exchange Commission (SEC) website.